BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 39 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,185,000 | -25.1% | 5,902,000 | -24.5% | 0.02% | -5.9% |
| Q4 2019 | $8,258,000 | -5.3% | 7,816,000 | -11.9% | 0.02% | -10.5% |
| Q3 2019 | $8,721,000 | -36.1% | 8,872,000 | -32.5% | 0.02% | -36.7% |
| Q2 2019 | $13,648,000 | +14.8% | 13,147,000 | +13.1% | 0.03% | +7.1% |
| Q1 2019 | $11,890,000 | -0.7% | 11,621,000 | -3.5% | 0.03% | -12.5% |
| Q4 2018 | $11,973,000 | -5.4% | 12,040,000 | +1.3% | 0.03% | +18.5% |
| Q3 2018 | $12,662,000 | -50.9% | 11,881,000 | -53.5% | 0.03% | -6.9% |
| Q2 2018 | $25,798,000 | +167.0% | 25,538,000 | +148.1% | 0.03% | +31.8% |
| Q1 2018 | $9,661,000 | +1296.1% | 10,292,000 | +1383.0% | 0.02% | +2100.0% |
| Q4 2017 | $692,000 | – | 694,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |